Literature DB >> 3799239

Prevalence of hyperglycaemia and undiagnosed diabetes mellitus in patients with acute myocardial infarction.

J K Madsen, S Haunsøe, S Helquist, E Hommel, I Malthe, N T Pedersen, H Sengeløv, D Rønnow-Jessen, S Telmer, H H Parving.   

Abstract

The prevalence of hyperglycaemia and undiagnosed diabetes mellitus was assessed in 214 consecutive patients admitted to the coronary care units with acute myocardial infarction (AMI). On admission, 16 patients (7.5%) had known diabetes, and 19 patients, not previously known to be diabetic, had blood glucose concentrations of greater than or equal to 9 mmol/l. Fifteen patients survived for 2 months at which time a 75 g oral glucose tolerance test showed diabetes in 9 (60%) and impaired glucose tolerance in 4 (27%). Ten of these 13 patients (77%) with abnormal glucose tolerance had elevated glycosylated haemoglobin (HbA1c) on admission, indicating pre-existing glucose intolerance or diabetes. The prevalence of undiagnosed diabetes was 4.5% (9/198). However, we may have overlooked undiagnosed diabetes in a small number of patients on admission, since only a random blood glucose less than 8 mmol/l rules out diabetes, WHO criteria. Elevated blood glucose in patients with AMI is more likely to reflect a stationary pre-existing abnormal glucose tolerance than a temporary stress-induced phenomenon.

Entities:  

Mesh:

Year:  1986        PMID: 3799239     DOI: 10.1111/j.0954-6820.1986.tb02773.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  2 in total

Review 1.  An overview of glycemic control in the coronary care unit with recommendations for clinical management.

Authors:  Mikhail Kosiborod; Prakash Deedwania
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

2.  Diabetes mellitus and impaired glucose tolerance are underdiagnosed in intensive care units.

Authors:  Renata Teixeira Ladeira; Ana Cinthia Marques Simioni; Antonio Tonete Bafi; Ana Paula Metran Nascente; Flavio Geraldo Resende Freitas; Flávia Ribeiro Machado
Journal:  Rev Bras Ter Intensiva       Date:  2012-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.